AEON Biopharma, Inc. Net Asset Quality Index
AEON Biopharma, Inc. net asset quality index. AEON Biopharma, Inc. (AEON) has a Net Asset Quality Index of -227.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $8.73 Million minus total liabilities of $28.61 Million yields net assets of $-19.87 Million. A higher index indicates a stronger, lower-leverage balance sheet. See AEON total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of AEON Biopharma, Inc. (2019–2024)
Net asset quality index of AEON Biopharma, Inc. from 2019 to 2024. This chart shows how AEON Biopharma, Inc.'s Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the index stands at -227.5%, representing net assets of $-19.87 Million against total assets of $8.73 Million USD. See AEON Biopharma, Inc. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
AEON Biopharma, Inc. Net Asset Quality Index by Year (2019–2024)
AEON Biopharma, Inc. net asset quality index by year from 2019 to 2024. The table below presents the year-by-year Net Asset Quality Index for AEON Biopharma, Inc. from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see AEON market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -909.3% | $-28.57 Million | $3.14 Million | $31.71 Million | ▲ +1326.6 pp |
| 2023 | -2235.9% | $-153.04 Million | $6.84 Million | $159.89 Million | ▲ +273.1 pp |
| 2022 | -2508.9% | $-270.41 Million | $10.78 Million | $281.19 Million | ▲ +968.8 pp |
| 2021 | -3477.7% | $-223.82 Million | $6.44 Million | $230.26 Million | ▼ -2519.7 pp |
| 2020 | -958.0% | $-203.23 Million | $21.21 Million | $224.45 Million | ▼ -900.4 pp |
| 2019 | -57.6% | $-65.87 Million | $114.35 Million | $180.22 Million | — |